Continuous glucose monitoring in the management of gestational diabetes in Switzerland (DipGluMo): an open-label, single-centre, randomised, controlled trial

Sofia Amylidi-Mohr, Giulia Zennaro, Sophie Schneider, Luigi Raio, Beatrice Mosimann, Daniel Surbek

Open source

DOI
10.1016/s2213-8587(25)00063-4
Published
2025-07
Container
The Lancet Diabetes & Endocrinology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s2213-8587-25-00063-4,
  title = {Continuous glucose monitoring in the management of gestational diabetes in Switzerland (DipGluMo): an open-label, single-centre, randomised, controlled trial},
  author = {Sofia Amylidi-Mohr and Giulia Zennaro and Sophie Schneider and Luigi Raio and Beatrice Mosimann and Daniel Surbek},
  year = {2025},
  journal = {The Lancet Diabetes \& Endocrinology},
  doi = {10.1016/s2213-8587(25)00063-4},
  url = {https://doi.org/10.1016/s2213-8587(25)00063-4}
}

RIS

TY  - JOUR
TI  - Continuous glucose monitoring in the management of gestational diabetes in Switzerland (DipGluMo): an open-label, single-centre, randomised, controlled trial
AU  - Sofia Amylidi-Mohr
AU  - Giulia Zennaro
AU  - Sophie Schneider
AU  - Luigi Raio
AU  - Beatrice Mosimann
AU  - Daniel Surbek
PY  - 2025
JO  - The Lancet Diabetes & Endocrinology
DO  - 10.1016/s2213-8587(25)00063-4
UR  - https://doi.org/10.1016/s2213-8587(25)00063-4
ER  - 

APA

Amylidi-Mohr, S., Zennaro, G., Schneider, S., Raio, L., Mosimann, B., & Surbek, D. (2025). Continuous glucose monitoring in the management of gestational diabetes in Switzerland (DipGluMo): an open-label, single-centre, randomised, controlled trial. The Lancet Diabetes & Endocrinology. https://doi.org/10.1016/s2213-8587(25)00063-4

Source records